1-9 of 9
A. Zander
Close
Sort by
Journal Articles

Phase II Multicenter Trial To Evaluate the Safety and Efficacy of Low-Toxicity Treosulfan/Fludarabine Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia.

Jerzy Holowiecki, S. Giebel, D. Beelen, R. Trenschel, H. Wandt, K. Schaefer-Eckart, T. Ruutu, L. Volin, H. Einsele, G. Stuhler, L. Uharek, I. Blau, M. Bornhaeuser, A. Zander, N. Kroeger, J. Aschan, J. Wojnar, M. Markiewicz, M. Freund, J. Casper
Journal: Blood
Blood (2007) 110 (11): 621.
https://doi.org/10.1182/blood.V110.11.621.621
Published: 2007
Journal Articles

A Phase 3, Randomized, Placebo-Controlled Trial of Filgrastim in Patients (Pts) with Hematologic Malignancies (HM) Treated with a Myeloablative Conditioning Regimen and Allogenic Bone Marrow Transplantation (allo BMT).

P. Ernst, A. Bacigalupo, O. Ringdén, T. Ruutu, A. Zander, H. Kolb, W. Siegert, P. Strijckmans, F. Zwaan, T. Skacel
Journal: Blood
Blood (2005) 106 (11): 2033.
https://doi.org/10.1182/blood.V106.11.2033.2033
Published: 2005
Journal Articles

High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors

HG Eckert, M Stockschlader, U Just, S Hegewisch-Becker, M Grez, A Uhde, A Zander, W Ostertag, C Baum
Journal: Blood
Blood (1996) 88 (9): 3407–3415.
https://doi.org/10.1182/blood.V88.9.3407.bloodjournal8893407
Published: 1996
Journal Articles

Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia transplanted with bone marrow from HLA-identical related donors [letter]

M Horstmann, M Stockschlader, H Kabisch, A Zander
Journal: Blood
Blood (1995) 85 (5): 1404–1405.
https://doi.org/10.1182/blood.V85.5.1404.bloodjournal8551404
Published: 1995
Journal Articles

Pentoxifylline did not prevent transplant-related toxicity in 31 consecutive allogeneic bone marrow transplant recipients [letter; comment]

P Kalhs, K Lechner, M Stockschlader, W Kruger, S Peters, A Zander
Journal: Blood
Blood (1992) 80 (10): 2683–2684.
https://doi.org/10.1182/blood.V80.10.2683.2683
Published: 1992
Journal Articles

High-dose melphalan with autologous bone marrow transplantation for multiple myeloma

B Barlogie, R Hall, A Zander, K Dicke, R Alexanian
Journal: Blood
Blood (1986) 67 (5): 1298–1301.
https://doi.org/10.1182/blood.V67.5.1298.1298
Published: 1986
Journal Articles

Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP)

MJ Keating, KB McCredie, RS Benjamin, GP Bodey, A Zander, TL Smith, EJ Freireich
Journal: Blood
Blood (1981) 58 (3): 584–591.
https://doi.org/10.1182/blood.V58.3.584.584
Published: 1981
Journal Articles

Host defense deficiency in hairy cell leukemia and its correction by leukocyte transfusion

EM Hersh, S Murphy, A Zander, K Dicke, DJ Stewart, H Toki, J Latreille
Journal: Blood
Blood (1980) 56 (3): 526–533.
https://doi.org/10.1182/blood.V56.3.526.526
Published: 1980
Journal Articles

The myeloid progenitor cell--its value in predicting hematopoietic recovery after autologous bone marrow transplantation

G Spitzer, DS Verma, R Fisher, A Zander, L Vellekoop, J Litam, KB McCredie, KA Dicke
Journal: Blood
Blood (1980) 55 (2): 317–323.
https://doi.org/10.1182/blood.V55.2.317.317
Published: 1980